Cheapest Mounjaro in Canada 2026: Pharmacy Prices, Discounts and Cost-Saving Strategies

Finding the cheapest Mounjaro in Canada takes real effort. Tirzepatide retail prices sit between $700 and $830 per month depending on dose, pharmacy and insurance — the most expensive of the major GLP-1 medications available in Canada. Provincial formularies cover it only for type 2 diabetes, and no generic is on the horizon within this decade. [1] [5]

This guide covers every legitimate path to lower Canadian Mounjaro cost: the cheapest retail pharmacies, online providers, the Eli Lilly patient-support program, private insurance strategies, the on-label Zepbound alternative for weight management, and where generics of other GLP-1s may shift the math in 2026.

• Cheapest retail: Costco Pharmacy (no membership required) — roughly $700–$740/month across doses.

• Provincial coverage: Only for type 2 diabetes (Ontario ODB, BC PharmaCare, etc.). Not covered for off-label weight management. [5]

• Private insurance: Widely covered under diabetes benefits; variable for weight management (off-label) or Zepbound (on-label).

• Patient support: Eli Lilly runs a Canadian patient-support program with savings on Mounjaro for eligible patients.

• Tax relief: Prescription Mounjaro qualifies for the Medical Expense Tax Credit — threshold $2,834 (2026). [7]

• Generic tirzepatide: Not imminent — Lilly's Canadian patents run well into the 2030s. Generic semaglutide (Ozempic) launched May 2026 at ~$88/month at Costco Pharmacy. [8]

Generic semaglutide (a different drug from Mounjaro) launched in Canada in May 2026 at ~$88/month at Costco. Mounjaro is tirzepatide and has no generic equivalent yet — Eli Lilly's patents extend through the mid-2030s. If your prescriber considers semaglutide clinically suitable for you (Ozempic-equivalent doses, type 2 diabetes), generic semaglutide is now significantly cheaper. → Read the full guide to generic semaglutide in Canada.

Online Providers Cost Comparison

Canadian telehealth clinics can assess, prescribe and arrange pharmacy delivery of Mounjaro — usually within 24–72 hours of intake. Consult fees vary; medication itself is priced in line with retail pharmacy rates.

Full reviews: MyRocky (top pick), Felix, Maple, Hims Canada, Jill Health, DooU and Raven.

Top pick: MyRocky (operated by Rocky Health Inc.) is our highest-rated Canadian GLP-1 provider in 2026 (9.4/10). Per-pen pricing is roughly comparable across the major Canadian telehealth services - what MyRocky wins on is total value: the $99 one-time consult includes lab work and the first prescription, there are no recurring quarterly fees, free fast delivery is included, and it operates its own LegitScript-certified pharmacy in Mississauga. MyRocky also serves all 10 provinces (Felix and Hims do not operate in Quebec) and has been trusted by 350,000+ Canadians. Visit MyRocky or read our full MyRocky review.

Pharmacy Price Comparison: Mounjaro by Dose

Approximate cash prices for a 4-week supply of Mounjaro pre-filled pens across major Canadian pharmacies in 2026. Each pen holds one dose, injected once weekly — a 4-pen box covers one month. [1]

Two observations: Costco consistently posts the lowest Canadian in-store price (no warehouse membership required for pharmacy use), and licensed online pharmacies like PocketPills are competitive on price with the added convenience of temperature-controlled shipping. Full Costco-specific breakdown: Mounjaro at Costco Canada.

Mounjaro Titration Schedule and Total First-Year Cost

Mounjaro uses a 6-step titration spread across about 20 weeks. Each step lasts 4 weeks to minimize GI side effects. Most patients do not climb all the way to 15 mg — adequate response at 5, 7.5 or 10 mg is common.

A full first year on Mounjaro at Costco pricing — titrated to 15 mg by week 21 — runs roughly $8,500–$8,900 out of pocket. At Rexall (top of the retail range) that figure pushes $9,700–$10,100. Patients who stop titrating at 7.5 mg or 10 mg will see meaningfully lower annual spend — map out the full year before committing.

Mounjaro vs Ozempic and Wegovy: Cost Comparison

Mounjaro is the most expensive GLP-1 class medication available in Canada — a direct reflection of Eli Lilly's pricing strategy and the dual GLP-1/GIP mechanism that drives its larger average weight-loss effect.

Mounjaro runs roughly $300–$450 more per month than Ozempic and $200–$400 more than Wegovy at maintenance doses. Head-to-head clinical comparisons: Mounjaro vs. Ozempic and Wegovy vs. Mounjaro.

One important note for weight-management patients: Zepbound is the same tirzepatide molecule as Mounjaro, but Health Canada–approved specifically for chronic weight management. Pricing is comparable to Mounjaro, but Zepbound removes the off-label objection with physicians and can improve private-insurance reimbursement under plans that cover on-label weight-management drugs. Details: Zepbound vs. Ozempic.

Strategies to Lower Your Mounjaro Cost

Every practical strategy Canadian patients use to reduce out-of-pocket Mounjaro cost, from biggest savings to smallest:

Strategies ranked by savings

Employer and private insurance

Most Canadian employer group plans cover Mounjaro when prescribed for type 2 diabetes — typical 80% coverage brings a $740/month Mounjaro cost to roughly $148 out of pocket. Coverage for off-label weight-management use is less common; Zepbound (on-label for weight) is often a cleaner fit for plans with weight-management drug benefits. Detailed coverage guide: Mounjaro Coverage in Canada.

Provincial coverage (type 2 diabetes only)

Mounjaro is listed on most Canadian provincial formularies for type 2 diabetes — Ontario Drug Benefit, BC PharmaCare, Alberta Blue Cross, RAMQ and others. Criteria typically require inadequate glycemic control on metformin or intolerance to other second-line agents. No province covers Mounjaro for off-label weight management. If weight loss is the goal without a T2D diagnosis, Zepbound (on-label) is generally a better insurance play than off-label Mounjaro. [5]

Eli Lilly patient support program

Eli Lilly Canada runs a patient-support program with savings cards and nurse-educator resources for Mounjaro patients. Eligibility depends on income, insurance status and province. Typical savings run $100–$200/month. Registration is through the prescribing clinic or Lilly's patient-support website. Full walkthrough: Mounjaro Savings Card Canada.

Ask about Zepbound or generic Ozempic

For weight-management patients, two alternatives can meaningfully lower cost: Zepbound (same tirzepatide molecule, on-label for weight — comparable price but better insurance outcomes) and off-label Ozempic (semaglutide at ~$250–$375/month, with newly launched generic semaglutide (May 2026) further dropping that to $100–$150/month). Both conversations are worth having with your prescriber if cost is the limiting factor.

Costco pharmacy and online options

Costco Pharmacy posts the lowest consistent Mounjaro price in Canada. No warehouse membership is required for pharmacy use. Licensed online pharmacies (PocketPills and similar) are price-competitive with Costco and add temperature-controlled home delivery. Full Costco breakdown including city-by-city pricing: Mounjaro at Costco Canada.

Practical steps

• Call at least three pharmacies before filling. Mounjaro cash prices can vary $50–$100/month between chains in the same city.

• Ask about price matching. Shoppers Drug Mart will sometimes match a documented competitor price.

• Apply for Lilly patient support before your first fill to avoid missing early-cycle savings.

• Review your benefits plan formulary annually — GLP-1 coverage is expanding year-over-year.

• Consider 90-day fills once on maintenance (one dispensing fee instead of three).

• Time higher-cost fills around insurance deductible thresholds to maximize coverage.

• For weight-management use, ask about Zepbound by name — it is the same molecule and removes the off-label objection in insurance billing.

Province-by-province pricing notes

• Ontario: ODB covers Mounjaro for T2D. Costco and Shoppers most competitive in Toronto and Ottawa.

• British Columbia: PharmaCare covers for T2D. London Drugs and Costco competitive in Vancouver.

• Alberta: Alberta Blue Cross covers for T2D. Calgary and Edmonton Costco locations consistently cheapest; online pharmacies often a better value outside major cities.

• Quebec: RAMQ covers for T2D. Montreal Costco and Pharmaprix lead on retail pricing.

• Atlantic provinces: Nova Scotia and New Brunswick Pharmacare both cover Mounjaro for T2D. Fewer chains competing on price means online pharmacies (PocketPills) are often the better value.

Generic Tirzepatide: Still Years Away

Unlike semaglutide — where Novo Nordisk's data exclusivity expired January 4, 2026 and Health Canada is already reviewing 9 generic applications — Eli Lilly's tirzepatide patents in Canada run well into the 2030s. No generic Mounjaro or Zepbound is imminent. [8]

The practical implication: patients waiting for a cheaper tirzepatide will be waiting several more years. Patients open to switching molecules have a nearer-term path — generic semaglutide launches May 2026 at a projected $100–$150/month, a 50–80% reduction from current branded Ozempic pricing. For type 2 diabetes or off-label weight management, switching to the semaglutide class can be a reasonable cost-driven option under prescriber guidance. Full timeline: Generic Semaglutide in Canada.

Generic Semaglutide at In-Person Canadian Pharmacies

Cash retail prices for generic semaglutide at Canadian pharmacies are now coming in below the telehealth alternatives, based on early Canadian consumer reports. Costco Pharmacy is the lowest reliable option at roughly $88 to $99 per month (confirmed pickups: $88.88 GTA, $88 Ontario, $99 Laval, $91 Medicine Hat). Walmart and Loblaws No Frills typically come in around $95 to $110 per month. Shoppers Drug Mart, Rexall and London Drugs are running roughly $100 to $120 per month (one Halifax-area Shoppers fill reported $113 for the 0.25mg starter dose). Apotex's Apo-Semaglutide Injection began shipping to Canadian pharmacies on May 20, 2026, with Dr. Reddy's generic also launching in May 2026.

That makes in-person pharmacies — especially Costco — meaningfully cheaper than telehealth providers for generic semaglutide. Felix Health and Hims Canada both list $149 per month all-in for the same generic Apo-Semaglutide on their public pricing pages. For most Canadians with a valid prescription, walking it into a local pharmacy is now the cheapest reliable path.

Pricing context: per the Globe and Mail, Apotex's published wholesale price is $78.14 for a four-week supply — roughly one-third of brand-name Ozempic's $240.48 wholesale price. Retail estimates above reflect that wholesale plus each chain's standard dispensing fee and markup. See also coverage from CBC News on the Canadian launch. Note: This generic launch is for semaglutide (Ozempic-equivalent), not tirzepatide. Generic Mounjaro is still years away — Eli Lilly's patents on tirzepatide extend through 2036+. Under the pan-Canadian Pharmaceutical Alliance framework, the maximum public drug plan price for generic semaglutide is approximately $114 per four-week supply with two manufacturers approved, dropping to roughly $80 once a third manufacturer launches.

FAQ

What is the cheapest way to get Mounjaro in Canada?

Provincial drug-plan coverage is the cheapest path — but only if you have a type 2 diabetes diagnosis. Employer group insurance is the next-best option (typical 80% coverage brings a $740 monthly cost to ~$148). Without coverage, the lowest retail cash price is Costco Pharmacy at roughly $700–$740/month (no membership required for pharmacy use). Stack the Eli Lilly patient-support card on top where eligible for another $100–$200/month reduction.

Does any Canadian province cover Mounjaro?

Yes — most provinces (Ontario ODB, BC PharmaCare, Alberta Blue Cross, RAMQ, Nova Scotia Pharmacare, New Brunswick Pharmacare) cover Mounjaro for type 2 diabetes patients who meet formulary criteria. No province covers Mounjaro for off-label weight management. Prior authorization is typically required.

Is Mounjaro cheaper than Ozempic or Wegovy?

No. Mounjaro is the most expensive of the three at maintenance doses — roughly $300–$450 more per month than Ozempic and $200–$400 more than Wegovy. The trade-off is the dual GLP-1/GIP mechanism, which produced ~20.9% mean weight loss at 15 mg in the SURMOUNT-1 trial. [2]

Is there a Mounjaro savings card in Canada?

Yes. Eli Lilly Canada runs a patient-support program with savings cards for eligible Mounjaro patients — typical savings of $100–$200 per month. Eligibility depends on income, insurance status and province. Full walkthrough: Mounjaro Savings Card Canada.

Is compounded tirzepatide safe or legal in Canada?

Compounded tirzepatide is not Health Canada–approved and availability is very limited. Quality control, sterility and dose accuracy vary between compounding facilities, and both Health Canada and the U.S. FDA have issued safety alerts about compounded GLP-1 products. Branded Mounjaro or Zepbound through a licensed Canadian pharmacy is the safer choice. [4]

Is Zepbound cheaper than Mounjaro?

No — pricing is comparable, because both are the same tirzepatide molecule sold by Eli Lilly. The practical advantage of Zepbound is on-label coverage for weight management: private plans that cover weight-management drugs will often reimburse Zepbound but not off-label Mounjaro, which can meaningfully reduce out-of-pocket cost depending on plan terms.

Can I deduct Mounjaro on my Canadian taxes?

Yes. Prescription Mounjaro qualifies for the Medical Expense Tax Credit. For the 2026 tax year, eligible medical expenses above $2,834 (or 3% of net income, whichever is less) generate a non-refundable federal credit plus a provincial component. A full year of out-of-pocket Mounjaro comfortably clears that threshold on its own. [7]

Sources

• Mounjaro (tirzepatide) Canadian Product Monograph — Eli Lilly Canada / Health Canada: Approved indications, dose-specific pens, titration schedule and safety profile.

• Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1) — Jastreboff AM et al., NEJM 2022: 72-week phase-3 registration trial; 20.9% mean weight loss on 15 mg.

• Eli Lilly Canada Patient Support Program — Mounjaro: Savings card, eligibility criteria and enrollment process.

• Compounded GLP-1 Safety Alert — Health Canada: Regulatory position on compounded tirzepatide and semaglutide products.

• Ontario Drug Benefit Formulary — Tirzepatide: Ontario public coverage criteria for Mounjaro (type 2 diabetes only).

• BC PharmaCare Limited Coverage — Mounjaro: British Columbia public coverage criteria.

• Medical Expense Tax Credit — Canada Revenue Agency: Eligible medical expenses, 2026 income thresholds and prescription-drug claim rules.

• Health Canada Drug Product Database — Mounjaro and Zepbound: Product listings, approved indications and current exclusivity/patent status.